November 9, 2026

Matthew Durdy, chief executive of the Cell and Gene Therapy Catapult (CGT Catapult), has announced his intention to retire in June 2027, following almost 15 years with the organisation, including...

Biological Sciences, Cell and gene therapy, CGT Catapult, Manufacturing, NHS, R&D